Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Appl Physiol (1985) ; 104(3): 648-54, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18174393

ABSTRACT

The main aim of this study was to investigate the bone-sparing effect of hesperidin, one of the main flavonoid present in oranges, in two age groups of ovariectomized female rats, compared with their intact controls. Young (3 mo) and adult (6 mo) female Wistar rats were sham operated (SH) or ovariectomized (OVX) and then pair-fed for 90 days a casein-based diet supplemented or not with 0.5% hesperidin (Hp; n = 10/group). In older rats, Hp intake led to a partial inhibition of OVX-induced bone loss, whereas a complete inhibition was obtained in younger animals. At both ages, while plasma osteocalcin concentrations were unchanged, urinary excretion of deoxypyridinoline was reduced by Hp intake, suggesting that Hp was able to slow down bone resorption. Unexpectedly, in intact young rats, Hp consumption resulted in a significant increase in bone mineral density (BMD). Indeed, 6-mo-old HpSH rats had a similar BMD to 9-mo-old nontreated SH adult rats, suggesting an accelerated bone mass gain in the young rats. In contrast, in intact adult rats, Hp did not further increase BMD but did improve their bone strength. The results of this study show a protective effect of Hp on bone loss in OVX rats of both ages without uterine stimulation and accompanied by a lipid-lowering effect. The unexpected and intriguing findings obtained in intact rats showing improved BMD in young rats and improved femoral load in adult rats merit further investigation. The bone and lipid benefits of hesperidin make it an attractive dietary agent for the management of the health of postmenopausal women.


Subject(s)
Bone Density Conservation Agents/pharmacology , Bone Density/drug effects , Bone Diseases, Metabolic/prevention & control , Bone Remodeling/drug effects , Hesperidin/pharmacology , Hypolipidemic Agents/pharmacology , Osteoporosis/prevention & control , Ovariectomy/adverse effects , Age Factors , Amino Acids/urine , Animals , Biomechanical Phenomena , Body Composition , Bone Density Conservation Agents/blood , Bone Density Conservation Agents/therapeutic use , Bone Diseases, Metabolic/etiology , Bone Diseases, Metabolic/metabolism , Bone Diseases, Metabolic/physiopathology , Bone Resorption/prevention & control , Cholesterol/blood , Disease Models, Animal , Female , Femur/drug effects , Femur/physiopathology , Hesperidin/blood , Hesperidin/therapeutic use , Hypolipidemic Agents/blood , Hypolipidemic Agents/therapeutic use , Osteocalcin/blood , Osteoporosis/etiology , Osteoporosis/metabolism , Osteoporosis/physiopathology , Rats , Rats, Wistar , Triglycerides/blood , Uterus/drug effects , Uterus/pathology
2.
Eur J Nutr ; 45(3): 171-7, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16155740

ABSTRACT

Low intracellular magnesium (Mg) contents may be observed in case of severe Mg insufficient intake or because of genetic regulation. This work was conducted to investigate the influence of intracellular Mg content on erythrocyte Mg(2+) influx and efflux in mice with low nutritionally and genetically (MGL and MGH mice) Mg status. C57BL6 mice were fed for 2 wks a diet containing 1000 mg Mg/kg diet Mg (control group), 100 mg Mg/kg diet (Mg-marginal group) or 30 mg Mg/kg diet (Mg deficient group), while mice with low (MGL) and high (MGH) Mg levels were fed a control diet for 2 wks. The quantification of erythrocyte Mg(2+) influx and efflux was performed using a stable isotope of Mg. Our results showed that erythrocyte Mg(2+) influx and efflux were respectively increased and decreased in nutritional Mg deficiency; while in genetically determined Mg status Mg(2+) fluxes were lower in MGL mice compared to MGH mice. Moreover Mg(2+) efflux was significantly correlated to Mg level in erythrocytes in all the mice studied (p < 0.001). In conclusion, erythrocyte Mg(2+) influx and efflux are modulated by low Mg status, namely decreased Mg(2+) efflux compensate for nutritional Mg deficiency, while the genetic regulation of erythrocyte Mg(2+) content depends on modification of Mg(2+) influx.


Subject(s)
Erythrocytes/metabolism , Magnesium Deficiency/metabolism , Magnesium/administration & dosage , Magnesium/metabolism , Nutritional Status , Animals , Animals, Genetically Modified , Dose-Response Relationship, Drug , Female , Homeostasis/genetics , Homeostasis/physiology , Magnesium/blood , Mice , Mice, Inbred C57BL
SELECTION OF CITATIONS
SEARCH DETAIL
...